Imène Hamaidi

645 total citations
9 papers, 328 citations indexed

About

Imène Hamaidi is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Imène Hamaidi has authored 9 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in Imène Hamaidi's work include Epigenetics and DNA Methylation (3 papers), Autophagy in Disease and Therapy (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Imène Hamaidi is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Autophagy in Disease and Therapy (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Imène Hamaidi collaborates with scholars based in United States, France and Taiwan. Imène Hamaidi's co-authors include Sungjune Kim, Anders Berglund, James J. Mulé, Ryan M. Putney, Rana Falahat, Glen N. Barber, Shari Pilon‐Thomas, Patricio Perez-Villarroel, Thierry Massfelder and Nayoung Kim and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nature Immunology.

In The Last Decade

Imène Hamaidi

8 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imène Hamaidi United States 8 168 117 80 57 47 9 328
Susan Wittig Germany 13 235 1.4× 62 0.5× 120 1.5× 28 0.5× 22 0.5× 25 387
Ania Wronski United States 11 315 1.9× 27 0.2× 153 1.9× 76 1.3× 48 1.0× 13 468
Yuki Katayama Japan 12 226 1.3× 81 0.7× 369 4.6× 120 2.1× 21 0.4× 30 619
Shuangshuang Lu China 12 143 0.9× 49 0.4× 133 1.7× 71 1.2× 5 0.1× 31 338
Xiaoxiao Xu China 11 176 1.0× 42 0.4× 44 0.6× 96 1.7× 5 0.1× 21 314
Yani Peng China 8 134 0.8× 91 0.8× 74 0.9× 33 0.6× 4 0.1× 31 323
Yuyang Lin China 9 132 0.8× 170 1.5× 154 1.9× 38 0.7× 3 0.1× 11 378
Daniel Nguyen United States 10 146 0.9× 19 0.2× 91 1.1× 65 1.1× 8 0.2× 22 326
Yuxiang Chen China 10 166 1.0× 58 0.5× 154 1.9× 132 2.3× 3 0.1× 26 367

Countries citing papers authored by Imène Hamaidi

Since Specialization
Citations

This map shows the geographic impact of Imène Hamaidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imène Hamaidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imène Hamaidi more than expected).

Fields of papers citing papers by Imène Hamaidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imène Hamaidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imène Hamaidi. The network helps show where Imène Hamaidi may publish in the future.

Co-authorship network of co-authors of Imène Hamaidi

This figure shows the co-authorship network connecting the top 25 collaborators of Imène Hamaidi. A scholar is included among the top collaborators of Imène Hamaidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imène Hamaidi. Imène Hamaidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hamaidi, Imène, Alak Manna, İsmail Can, et al.. (2026). SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling. Nature Immunology. 27(2). 213–224.
2.
Falahat, Rana, Anders Berglund, Patricio Perez-Villarroel, et al.. (2023). Epigenetic state determines the in vivo efficacy of STING agonist therapy. Nature Communications. 14(1). 56 indexed citations
3.
Hamaidi, Imène & Sungjune Kim. (2022). Sirtuins are crucial regulators of T cell metabolism and functions. Experimental & Molecular Medicine. 54(3). 207–215. 45 indexed citations
4.
Berglund, Anders, Ryan M. Putney, Imène Hamaidi, & Sungjune Kim. (2021). Epigenetic dysregulation of immune-related pathways in cancer: bioinformatics tools and visualization. Experimental & Molecular Medicine. 53(5). 761–771. 21 indexed citations
5.
Hamaidi, Imène, Lin Zhang, Nayoung Kim, et al.. (2020). Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells. Cell Metabolism. 32(3). 420–436.e12. 93 indexed citations
6.
Berglund, Anders, Matthew N. Mills, Ryan M. Putney, et al.. (2019). Methylation of immune synapse genes modulates tumor immunogenicity. Journal of Clinical Investigation. 130(2). 974–980. 30 indexed citations
7.
Hamaidi, Imène, Sabrina Danilin, Manon Ripoll, et al.. (2018). Polydiacetylenic nanofibers as new siRNA vehicles for in vitro and in vivo delivery. Nanoscale. 10(4). 1587–1590. 17 indexed citations
8.
Hamaidi, Imène, Catherine Coquard, Sabrina Danilin, et al.. (2018). The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma. Oncogene. 38(1). 60–72. 16 indexed citations
9.
Dufour, Florent, Hélène Neyret‐Kahn, C Béraud, et al.. (2018). An FGFR 3/ MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers. EMBO Molecular Medicine. 10(4). 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026